Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or ...

Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives ...

The other experimental drug is bimagrumab, which is designed to help patients on weight loss medications from losing too much ...

I used to spend about 60% of each day thinking about food—when was the next meal? What was I going to eat? Would it be ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...

Researchers have homed in on a single gut microbe that acts to prevent fat gain, even with a high-fat diet. The discovery ...

Eli Lilly’s experimental weight-loss drug retatrutide led to an average weight reduction of up to 28.7%—more than 71 ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...